XML 45 R27.htm IDEA: XBRL DOCUMENT
v3.23.1

Licensed rights and other intangible assets (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Goodwill And Intangible Assets Disclosure [Abstract] |
Summary of Information about License Rights and Other Intangible Assets, Net | The following provides information about our license rights and other intangible assets, net (in thousands):
|  | As of December 31, 2022 |  |  | As of December 31, 2021 |
|  | Gross |  |  |  |  |  |  |  |  |  |  | Gross |  |  |  |  |  |  |  |  |
|  | Carrying |  |  | Accumulated |  |  |  |  |  |  | Carrying |  |  | Accumulated |  |  |  |  |
|  | Amount |  |  | Amortization |  |  | Net |  |  | Amount |  |  | Amortization |  |  | Net |
Intangible assets subject to amortization: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Hormone therapy drug patents |  | $ | 6,225 |  |  | $ | 1,598 |  |  | $ | 4,627 |  |  | $ | 5,834 |  |  | $ | 1,042 |  |  | $ | 4,792 |
Hormone therapy drug patents applied and pending approval |  |  | 1,995 |  |  |  | — |  |  |  | 1,995 |  |  |  | 2,020 |  |  |  | — |  |  |  | 2,020 |
Intangible assets subject to amortization |  |  | 8,220 |  |  |  | 1,598 |  |  |  | 6,622 |  |  |  | 7,854 |  |  |  | 1,042 |  |  |  | 6,812 |
Intangible assets not subject to amortization: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trademarks/trade name rights |  |  | 321 |  |  |  | — |  |  |  | 321 |  |  |  | 332 |  |  |  | — |  |  |  | 332 |
Intangible assets, net |  | $ | 8,541 |  |  | $ | 1,598 |  |  | $ | 6,943 |  |  | $ | 8,186 |  |  | $ | 1,042 |  |  | $ | 7,144 |
Summary of Intangible Assets Subject To Amortization Is Expected To Be Amortized | Our intangible assets subject to amortization are expected to be amortized as follows (in thousands):
Year ending December 31, |
2023 |  | $ | 337 |
2024 |  |  | 439 |
2025 |  |  | 438 |
2026 |  |  | 438 |
2027 |  |  | 438 |
Thereafter |  |  | 2,537 |
Total |  | $ | 4,627 |

X
- Definition Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration